Clinical trials
Terminated Insulinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 2 |
| Barts & The London NHS Trust | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Emory University | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| National Cancer Institute (NCI) | 1 |
| University of California, San Francisco | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulinoma | 9 |
| Glucagonoma | 8 |
| Somatostatinoma | 8 |
| Carcinoma, Islet Cell | 7 |
| Gastrinoma | 7 |
| Adenoma, Islet Cell | 4 |
| Neoplasms | 3 |
| Vipoma | 3 |
| Carcinoma, Medullary | 2 |
| Carcinoma, Renal Cell | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.